ScholarIQanswers from OpenAlex
Erasmus Hospital
InstitutionResearch output, impact & collaborations
Erasmus Hospital is a institution indexed in ScholarIQ from OpenAlex.
What is known about Erasmus Hospital?
ScholarIQrecord summary
Erasmus Hospital is a research organisation in Brussels, BE. OpenAlex records 16,474 works and 1,697,803 citations for it. 3,014 researchers list it as their most recent affiliation.
How many works does Erasmus Hospital have?
ScholarIQindexed works
Erasmus Hospital has 16,474 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Erasmus Hospital have?
ScholarIQcitation count
Erasmus Hospital has 1,697,803 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Erasmus Hospital?
ScholarIQresearcher count
Erasmus Hospital has 3,014 researchers in the ScholarIQ index.
What is the average h-index at Erasmus Hospital?
ScholarIQavg h-index
Erasmus Hospital has an average h-index of 22.8 in OpenAlex.
What is the ROR of Erasmus Hospital?
ScholarIQror
The ROR for Erasmus Hospital is on the source record.
What is the OpenAlex record for Erasmus Hospital?
ScholarIQopenalex
The OpenAlex for Erasmus Hospital is on the source record.
What is the Wikidata of Erasmus Hospital?
ScholarIQwikidata
The Wikidata for Erasmus Hospital is on the source record.
Who are the most-cited researchers behind Erasmus Hospital?
ScholarIQtop researchers by citations
What are the most-cited papers on Erasmus Hospital?
ScholarIQmost cited works
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Marc Humbert, Gábor Kovács, Marius M. Hoeper, Roberto Badagliacca, Rolf M.F. Berger, Margarita Brida, Jørn Carlsen, Andrew J.S. Coats, Pilar Escribano Subías, Pisana Ferrari, Diogenes S. Ferreira, Hossein Ardeschir Ghofrani, George Giannakoulas, David G. Kiely, Eckhard Mayer, Gergely Mészáros, Blin Nagavci, Karen M. Olsson, Joanna Pepke‐Żaba, Jennifer K Quint, Göran Rådegran, Gérald Simonneau, Olivier Sitbon, Thomy Tonia, Mark Toshner, Jean-Luc Vachiéry, Anton Vonk Noordegraaf, Marion Delcroix, Stephan Rosenkranz, the ESC/ERS Scientific Document Group
<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma
Ferdinandos Skoulidis, Michael E. Goldberg, Danielle Greenawalt, Matthew D. Hellmann, Mark M. Awad, Justin F. Gainor, Alexa B. Schrock, Ryan J. Hartmaier, Sally E. Trabucco, Laurie M. Gay, Siraj M. Ali, Julia A. Elvin, Gaurav Singal, Jeffrey S. Ross, David Fabrizio, Péter M. Szabó, Chang Han, Ariella Sasson, Sujaya Srinivasan, Stefan Kirov, Joseph D. Szustakowski, Patrik Vitazka, Robin Edwards, José A. Bufill, Neelesh Sharma, Sai‐Hong Ignatius Ou, Nir Peled, David R. Spigel, Hira Rizvi, Elizabeth Jiménez Aguilar, Brett W. Carter, Jeremy Erasmus, Darragh Halpenny, Andrew J. Plodkowski, Niamh M. Long, Mizuki Nishino, Warren L. Denning, Ana Galán‐Cobo, Haïfa Hamdi, Taghreed Hirz, Pan Tong, Jing Wang, Jaime Rodriguez‐Canales, Pamela Villalobos, Edwin R. Parra, Neda Kalhor, Lynette M. Sholl, Jennifer L. Sauter, Achim A. Jungbluth, Mari Mino–Kenudson, Roxana Azimi, Yasir Y. Elamin, Jianjun Zhang, Giulia C. Leonardi, Fei Jiang, Kwok‐Kin Wong, J. Jack Lee, Vassiliki A. Papadimitrakopoulou, Ignacio I. Wistuba, Vincent A. Miller, Garrett M. Frampton, Jedd D. Wolchok, Alice T. Shaw, Pasi A. Jänne, Philip J. Stephens, Charles M. Rudin, William J. Geese, Lee A. Albacker, John V. Heymach
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
Hussein A. Tawbi, Melissa Burgess, Vanessa Bolejack, Brian A. Van Tine, Scott M. Schuetze, James Hu, Sandra P. D’Angelo, Steven Attia, Richard F. Riedel, Dennis A. Priebat, Sujana Movva, Lara E. Davis, Scott H. Okuno, Damon R. Reed, John Crowley, Lisa H. Butterfield, Ruth Salazar, Jaime Rodriguez‐Canales, Alexander J. Lazar, Ignacio I. Wistuba, Laurence H. Baker, Robert G. Maki, Denise K. Reinke, Shreyaskumar Patel
A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition
Milena Perez Mak, Pan Tong, Lixia Diao, Robert J. Cardnell, Don L. Gibbons, William N. William, Ferdinandos Skoulidis, Edwin R. Parra, Jaime Rodriguez‐Canales, Ignacio I. Wistuba, John V. Heymach, John N. Weinstein, Kevin R. Coombes, Jing Wang, Lauren A. Byers
CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade
Limo Chen, Lixia Diao, Yongbin Yang, Xiaohui Yi, B. Leticia Rodriguez, Yanli Li, Pamela Villalobos, Tina Cascone, Xi Liu, Lin Tan, Philip L. Lorenzi, Anfei Huang, Qiang Zhao, Di Peng, Jared J. Fradette, David H. Peng, Christin Ungewiss, Jonathon D. Roybal, Pan Tong, Junna Oba, Ferdinandos Skoulidis, Weiyi Peng, Brett W. Carter, Carl M. Gay, You-Hong Fan, Caleb A. Class, Jingfen Zhu, Jaime Rodriguez‐Canales, Masanori Kawakami, Lauren A. Byers, Scott E. Woodman, Vassiliki A. Papadimitrakopoulou, Ethan Dmitrovsky, Jing Wang, Stephen E. Ullrich, Ignacio I. Wistuba, John V. Heymach, F. Xiao‐Feng Qin, Don L. Gibbons
How much of the research on Erasmus Hospital is open access?
ScholarIQopen access share
67%OPEN ACCESS